Sensitive detection of clonal antigen receptor gene rearrangements in Non- Hodgkin's malignant lymphoma with an anchored polymerase chain reaction- based strategy

H. Ratech, A. Masih

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The identification of minimal residual disease (MRD) in non-Hodgkin's malignant lymphoma is of immediate clinical relevance. Although several polymerase chain reaction (PCR)-based strategies are currently available, they all share serious technical or theoretic limitations with respect to their ability to detect the broad spectrum of mature B-cell neoplasia. We report a new strategy based on anchored PCR that does not rely on a particular chromosomal translocation or V(H) consensus sequence. It can yield the complete DNA sequence of the immunoglobulin heavy chain variable region (V(H)DJ(H)). The assay is capable of detecting one neoplastic cell among 103-104 normal cells with high specificity and has the potential to greatly expand the variety of B-cell malignant neoplasms that can be studied.

Original languageEnglish (US)
Pages (from-to)527-533
Number of pages7
JournalAmerican journal of clinical pathology
Volume100
Issue number5
DOIs
StatePublished - 1993

Keywords

  • Gene rearrangement
  • Immunoglobulin variable region
  • Minimal residual disease
  • Non-Hodgkin's malignant lymphoma
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Sensitive detection of clonal antigen receptor gene rearrangements in Non- Hodgkin's malignant lymphoma with an anchored polymerase chain reaction- based strategy'. Together they form a unique fingerprint.

Cite this